Clinical Trial Update: Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease [Phase 2]

View source ↗

Summary

Report on a Phase 2 clinical trial evaluating extracorporeal shock wave therapy for ischemic heart disease in patients with refractory angina pectoris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina
• Ischemic Heart Disease

Snippet

Sponsor: Medispec | Conditions: Refractory Angina Pectoris | Phase 2 | Status: UNKNOWN